A new $7.4 billion opioid settlement for Purdue Pharma and the Sackler family has been approved by all U.S. states and ...

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 ...

The multi-billion-dollar payment is meant to resolve claims that the drugmaker's pain medication, OxyContin, caused an opioid ...

The long-running Purdue Pharma case may finally be over. All attorneys general from U.S. states, territories, districts and ...

Fifty-five state attorneys general have agreed to a $7.4 billion settlement with Purdue Pharma and the Sackler family over ...

The DOJ's bankruptcy watchdog agency challenged earlier settlement attempts, leading to the U.S. Supreme Court's decision to overturn a previous bankruptcy deal with Purdue Pharma and Sacklers in ...

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

According to the company, a major change from past settlement deals will ... SUMMERS: So Brian, Purdue Pharma and the Sacklers, they've tried to reach settlements before. Those have been shot ...